CTXR logo

Citius Pharmaceuticals (CTXR) Shareholders Equity

Annual Shareholders Equity

$90.83 M
-$11.99 M-11.67%

30 September 2023

CTXR Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Shareholders Equity

$85.68 M
+$6.32 M+7.96%

30 June 2024

CTXR Quarterly Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CTXR Shareholders Equity Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year--5.7%
3 y3 years-31.3%-35.2%
5 y5 years+234.5%+215.6%

CTXR Shareholders Equity High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-31.3%at low-35.2%+8.0%
5 y5 years-31.3%+234.5%-37.3%+320.5%
alltimeall time-31.3%>+9999.0%-37.3%+5488.3%

Citius Pharmaceuticals Shareholders Equity History

DateAnnualQuarterly
June 2024
-
$85.68 M(+8.0%)
Mar 2024
-
$79.37 M(-6.3%)
Dec 2023
-
$84.73 M(-6.7%)
Sept 2023
$90.83 M(-11.7%)
$90.83 M(-7.0%)
June 2023
-
$97.70 M(+7.1%)
Mar 2023
-
$91.21 M(-9.2%)
Dec 2022
-
$100.43 M(-2.3%)
Sept 2022
-
$102.83 M(-6.3%)
Sept 2022
$102.83 M(-22.2%)
-
June 2022
-
$109.74 M(-6.7%)
Mar 2022
-
$117.60 M(-5.1%)
Dec 2021
-
$123.96 M(-6.2%)
Sept 2021
$132.18 M(+292.6%)
$132.18 M(-3.3%)
June 2021
-
$136.68 M(+9.2%)
Mar 2021
-
$125.16 M(+396.7%)
Dec 2020
-
$25.20 M(-25.2%)
Sept 2020
$33.67 M(+24.0%)
$33.67 M(+17.1%)
June 2020
-
$28.74 M(+28.1%)
Mar 2020
-
$22.44 M(+10.1%)
Dec 2019
-
$20.38 M(-25.0%)
Sept 2019
$27.15 M(-2.6%)
$27.15 M(+26.3%)
June 2019
-
$21.51 M(+3.0%)
Mar 2019
-
$20.87 M(-13.7%)
Dec 2018
-
$24.18 M(-13.2%)
Sept 2018
$27.87 M
$27.87 M(+28.8%)
June 2018
-
$21.64 M(-7.9%)
Mar 2018
-
$23.50 M(-9.1%)
DateAnnualQuarterly
Dec 2017
-
$25.86 M(+17.8%)
Sept 2017
$21.95 M(+30.9%)
$21.95 M(+89.3%)
June 2017
-
$11.59 M(-17.1%)
Mar 2017
-
$13.99 M(-7.7%)
Dec 2016
-
$15.16 M(-9.6%)
Sept 2016
$16.77 M(-2739.5%)
$16.77 M(-7.7%)
June 2016
-
$18.16 M(-11.1%)
Mar 2016
-
$20.43 M(-1384.5%)
Dec 2015
-
-$1.59 M(+150.3%)
Sept 2015
-$635.20 K(-14.4%)
-$635.20 K(-46.2%)
June 2015
-
-$1.18 M(+28.6%)
Mar 2015
-
-$918.00 K(+11.5%)
Dec 2014
-
-$823.50 K(+11.0%)
Sept 2014
-$741.90 K(+4946.9%)
-$741.90 K(+2262.7%)
June 2014
-
-$31.40 K(+25.1%)
Mar 2014
-
-$25.10 K(+67.3%)
Dec 2013
-
-$15.00 K(+2.0%)
Sept 2013
-$14.70 K(-67.9%)
-$14.70 K(-76.3%)
June 2013
-
-$61.90 K(+7.7%)
Mar 2013
-
-$57.50 K(+21.6%)
Dec 2012
-
-$47.30 K(+3.3%)
Sept 2012
-$45.80 K(+92.4%)
-$45.80 K(+13.1%)
June 2012
-
-$40.50 K(+20.5%)
Mar 2012
-
-$33.60 K(+27.3%)
Dec 2011
-
-$26.40 K(+10.9%)
Sept 2011
-$23.80 K
-$23.80 K(+12.8%)
June 2011
-
-$21.10 K

FAQ

  • What is Citius Pharmaceuticals annual stockholders equity?
  • What is the all time high annual shareholders equity for Citius Pharmaceuticals?
  • What is Citius Pharmaceuticals quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Citius Pharmaceuticals?
  • What is Citius Pharmaceuticals quarterly shareholders equity year-on-year change?

What is Citius Pharmaceuticals annual stockholders equity?

The current annual shareholders equity of CTXR is $90.83 M

What is the all time high annual shareholders equity for Citius Pharmaceuticals?

Citius Pharmaceuticals all-time high annual stockholders equity is $132.18 M

What is Citius Pharmaceuticals quarterly stockholders equity?

The current quarterly shareholders equity of CTXR is $85.68 M

What is the all time high quarterly shareholders equity for Citius Pharmaceuticals?

Citius Pharmaceuticals all-time high quarterly stockholders equity is $136.68 M

What is Citius Pharmaceuticals quarterly shareholders equity year-on-year change?

Over the past year, CTXR quarterly stockholders equity has changed by -$5.15 M (-5.67%)